Actress Neetu Chandra on Monday attended the Memorandum of Understanding (MoU) signing ceremony of the Bihar government with Tata Memorial Hospital concerning the availability of special aid for the cancer patients in Bihar.
According to the signed MoU, an amount of Rs 1 lakh would be provided to the victim.
Proud to witness the collaboration, Neetu said in a statement: "It's a wonderful initiative and I am so blessed to have witnessed this collaboration. I am delighted that 70 per cent to 80 per cent aid will be provided to patients from Bihar under the annual income of Rs 2.5 lakh."
The "Garam Masala" star, who lost her father to Cancer six years ago, said that her "heart breaks when she sees people helpless".
"Good health is a blessing and my heart breaks when I see people helpless and unable to afford medical attention," she added.--IANS
sim/dc/sed
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app